blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2043658

EP2043658 - ANTIVIRAL PHOSPHINATE COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.03.2013
Database last updated on 24.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
[2009/15]
Inventor(s)01 / CASAREZ, Anthony
218 Harrison Lane, Apt. B
Princeton, NJ 08540 / US
02 / CHAUDHARY, Kleem
11 Newman Street
Cambridge, MA 02140 / US
03 / CHO, Aesop
1656 Notre Dame Drive
Mountain View, CA 94040 / US
04 / CLARKE, Michael
400 Baltic Circle 410
Redwood City, CA 94065 / US
05 / DOERFFLER, Edward
752 Bounty Drive 5203
Foster City, CA 94404 / US
06 / FARDIS, Maria
105 Aberdeen Drive
San Carlos, CA 94070 / US
07 / KIM, Choung, U.
1750 Elizabeth Street
San Carlos, CA 94070 / US
08 / PYUN, Hyungjung
3368 Sanderling Drive
Fremont, CA 94555 / US
09 / SHENG, Xiaoning C.
736 Bounty Drive 3611
Foster City, CA 94404 / US
10 / WANG, Jianying
770 Crane Avenue
Foster City, CA 94404 / US
 [2009/17]
Former [2009/15]01 / CASAREZ, Anthony
1661 Bush Street 7
San Francisco, CA 94109 / US
02 / CHAUDHARY, Kleem
11 Newman Street
Cambridge, MA 02140 / US
03 / CHO, Aesop
1656 Notre Dame Drive
Mountain View, CA 94040 / US
04 / CLARKE, Michael
400 Baltic Circle 410
Redwood City, CA 94065 / US
05 / DOERFFLER, Edward
752 Bounty Drive 5203
Foster City, CA 94404 / US
06 / FARDIS, Maria
105 Aberdeen Drive
San Carlos, CA 94070 / US
07 / KIM, Choung, U.
1750 Elizabeth Street
San Carlos, CA 94070 / US
08 / PYUN, Hyungjung
3368 Sanderling Drive
Fremont, CA 94555 / US
09 / SHENG, Xiaoning C.
736 Bounty Drive 3611
Foster City, CA 94404 / US
10 / WANG, Jianying
770 Crane Avenue
Foster City, CA 94404 / US
Representative(s)Reitstötter Kinzebach
Patentanwälte
Sternwartstraße 4
81679 München / DE
[N/P]
Former [2012/17]Reitstötter - Kinzebach
Patentanwälte Sternwartstrasse 4
81679 München / DE
Former [2009/15]Reitstötter - Kinzebach
Patentanwälte Sternwartstrasse 4
81679 München / DE
Application number, filing date07796752.906.07.2007
[2009/15]
WO2007US15664
Priority number, dateUS20060819488P07.07.2006         Original published format: US 819488 P
US20060832908P24.07.2006         Original published format: US 832908 P
[2009/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008005565
Date:10.01.2008
Language:EN
[2008/02]
Type: A2 Application without search report 
No.:EP2043658
Date:08.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application.
[2009/15]
Type: B1 Patent specification 
No.:EP2043658
Date:25.04.2012
Language:EN
[2012/17]
Search report(s)International search report - published on:EP02.05.2008
ClassificationIPC:A61K31/662, A61P31/12, C07F9/572, C07F9/6558
[2009/15]
CPC:
C07F9/65583 (EP,US); C07D401/14 (KR); A61K31/662 (KR);
A61P1/16 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P43/00 (EP); C07D401/12 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/15]
Extension statesAL20.01.2009
BA20.01.2009
HR20.01.2009
MK20.01.2009
RS20.01.2009
TitleGerman:ANTIVIRALE PHOSPHINATVERBINDUNGEN[2009/15]
English:ANTIVIRAL PHOSPHINATE COMPOUNDS[2009/15]
French:COMPOSÉS ANTIVIRAUX DE PHOSPHINATE[2009/15]
Entry into regional phase20.01.2009National basic fee paid 
20.01.2009Designation fee(s) paid 
20.01.2009Examination fee paid 
Examination procedure20.01.2009Amendment by applicant (claims and/or description)
20.01.2009Examination requested  [2009/15]
16.11.2009Despatch of a communication from the examining division (Time limit: M04)
25.03.2010Reply to a communication from the examining division
20.04.2010Despatch of a communication from the examining division (Time limit: M06)
29.10.2010Reply to a communication from the examining division
27.05.2011Despatch of a communication from the examining division (Time limit: M04)
16.08.2011Reply to a communication from the examining division
21.10.2011Communication of intention to grant the patent
17.02.2012Fee for grant paid
17.02.2012Fee for publishing/printing paid
Divisional application(s)EP11190674.9  / EP2422791
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.11.2009
Opposition(s)28.01.2013No opposition filed within time limit [2013/14]
Fees paidRenewal fee
28.07.2009Renewal fee patent year 03
26.07.2010Renewal fee patent year 04
25.07.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.07.2007
AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MT25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
TR25.04.2012
IE06.07.2012
LU06.07.2012
BG25.07.2012
GR26.07.2012
CH31.07.2012
LI31.07.2012
MC31.07.2012
IS25.08.2012
PT27.08.2012
[2014/34]
Former [2014/27]AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MT25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
TR25.04.2012
IE06.07.2012
LU06.07.2012
BG25.07.2012
GR26.07.2012
CH31.07.2012
LI31.07.2012
MC31.07.2012
IS25.08.2012
PT27.08.2012
Former [2014/21]AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MT25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
TR25.04.2012
IE06.07.2012
BG25.07.2012
GR26.07.2012
CH31.07.2012
LI31.07.2012
MC31.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/34]AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
MT25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
IE06.07.2012
BG25.07.2012
GR26.07.2012
CH31.07.2012
LI31.07.2012
MC31.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/33]AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
IE06.07.2012
GR26.07.2012
CH31.07.2012
LI31.07.2012
MC31.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/20]AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
GR26.07.2012
CH31.07.2012
LI31.07.2012
MC31.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/11]AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
GR26.07.2012
MC31.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/10]AT25.04.2012
BE25.04.2012
CY25.04.2012
CZ25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
RO25.04.2012
SE25.04.2012
SI25.04.2012
SK25.04.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/09]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
EE25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/08]AT25.04.2012
BE25.04.2012
CY25.04.2012
DK25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
NL25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/07]AT25.04.2012
BE25.04.2012
CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/04]BE25.04.2012
CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2013/01]CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
GR26.07.2012
IS25.08.2012
PT27.08.2012
Former [2012/51]CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
SI25.04.2012
GR26.07.2012
IS25.08.2012
Former [2012/50]CY25.04.2012
FI25.04.2012
LT25.04.2012
LV25.04.2012
PL25.04.2012
SE25.04.2012
GR26.07.2012
IS25.08.2012
Former [2012/49]CY25.04.2012
FI25.04.2012
LT25.04.2012
PL25.04.2012
SE25.04.2012
IS25.08.2012
Former [2012/48]FI25.04.2012
LT25.04.2012
SE25.04.2012
Former [2012/47]LT25.04.2012
Cited inInternational search[A]US6004977  (KURYS BARBARA E [US], et al) [A] 1,54 * claims 3,17; table 1 *;
 [X]WO2006020276  (GILEAD SCIENCES INC [US], et al) [X] 1,3-5,10-14,21,47-49,62,54,55,59 * claims 37,41-45 * * claim 46 * * claim 49 *;
 [PA]WO2006109085  (ASTEX THERAPEUTICS LTD [GB], et al) [PA] 1,54* page 32, line 10 - line 16; examples 36,68,79,81,82; table 2; compounds B48,B96 *;
 [PA]WO2007014922  (TIBOTEC PHARM LTD [IE], et al) [PA] 1,3,54,55,59 * example 98; claims 10,11; table 1; compound 1 *;
 [A]  - FRAY ET AL, "Synthesis of substituted 5-aminomethyl tetrahydro-isoquinolines and dihydro-isoindoles", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20060521), vol. 62, no. 29, ISSN 0040-4020, pages 6869 - 6875, XP005496592 [A] 1 * table 2; compound 13B *

DOI:   http://dx.doi.org/10.1016/j.tet.2006.04.095
ExaminationDE19843360
    - ISSLEIB K. ET AL., "Phospha-Pharmaca - Antibacterial and Viricidic Compounds", PHOSPHORUS AND SULFUR, (1987), vol. 30, pages 633 - 636, XP009132071
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.